Future of SoftwareStart Survey

Benevolent AI

AI platform combining machine learning and biomedical data to accelerate drug discovery.

Headquarters
London, United Kingdom
Company size
201-500 employees
Founded
2013

Product overview

  • AI-powered drug discovery
  • Knowledge graph and ontology management
  • Strategic decision support for biopharma

Buyer research

Unlock the full Benevolent AI profile

Create a free account and complete onboarding for buyer research and procurement details.

Checking profile access…
Is this your product?Claim this profile